Structured Data Objects

Sections

Section fields

  • id: Unique section identifier (e.g., "s1", "s2a")

  • level: Hierarchy depth (1 = main, 2 = subsection, etc.)

  • order: Display order within the document

  • title: Original section title

  • anchor: URL-safe identifier

  • category: Semantic category (introduction, methods, results, discussion, etc.)

  • path_anchor: Full hierarchical path

  • path_anchors: Array of parent section anchors

  • normalized_title: Cleaned title

  • top_normalized_title: Top-level section title

SECTIONS OBJECT
{
   "public_id":"1642632597.v1",
   "open_access":true,
   "normalized":true,
   "updated_at":"2025-10-12T20:44:54.501Z",
   "data":{
      "sections":[
         {
            "id":"s2",
            "level":1,
            "order":1,
            "title":"METHODS",
            "anchor":"methods",
            "category":"methods",
            "path_anchor":"methods",
            "normalized_title":"Methods",
            "top_normalized_title":"Methods"
         },
         {
            "id":"s2a",
            "level":2,
            "order":2,
            "title":"Dosimetry",
            "anchor":"dosimetry",
            "category":"methods",
            "path_anchor":"methods/dosimetry",
            "path_anchors":[
               "methods"
            ],
            "normalized_title":"Methods",
            "top_normalized_title":"Methods"
         }
      ]
   }
}

Assets

Assets fields

  • id: Unique asset identifier (e.g., "tbl1", "fig1")

  • hash: SHA-256 checksum for integrity verification

  • label: Display label (e.g., "Table 1.", "Figure 1.")

  • title: Asset title (if available)

  • caption_text: Caption text

ASSETS OBJECT
{
   "public_id":"1642632597.v1",
   "open_access":true,
   "normalized":true,
   "updated_at":"2025-10-12T20:44:54.501Z",
   "data":{
      "assets":{
         "tables":[
            {
               "id":"tbl1",
               "hash":"sha256:abc123def456789...",
               "label":"Table 1.",
               "title":Patient demographics and baseline characteristics",
               "caption_text":"Patient and lesion characteristics as previously reported (7)"
            },
         ],
         "figures":[
            {
               "id":"fig1",
               "hash":"sha256:def456abc789123...",
               "label":"Figure 1.",
               "caption_text":"Study flow diagram showing patient enrollment"
            }  
         ]
      }
   }
}

Blocks

Block fields

  • kind: Content type (paragraph, list, equation, etc.)

  • order: Document order

  • raw_xml: Original XML from the source document

  • block_id: Unique block identifier

  • path_anchor: Hierarchical path within the document

  • index_in_section: Position within the parent section

  • xrefs: Array of cross-references (optional)

  • plain_text: Plain text content

  • section_id: Parent section identifier

  • minimal_xml: Simplified XML with essential formatting

Cross-reference fields (when present)

  • span: Character range [start, end] in plain text

  • type: Reference type (citation, table-ref, figure-ref, extlink, etc.)

  • label: Display label

  • target_id: Target identifier

ASSETS OBJECT
 {
    "public_id":"ver:medrxiv:2025.08.07.25333034:v1",
    "open_access":true,
    "normalized":true,
    "updated_at":"2025-01-15T10:30:00.000Z",
    "data":{
       "blocks":[
          {
             "kind":"paragraph",
             "order":1,
             "block_id":"b2103236719886133",
             "section_id":"s2a",
             "path_anchor":"methods/dosimetry",
             "index_in_section":4,
             "xrefs":[
                {
                   "span":[143, 154],
                   "type":"extlink",
                   "label":"NCT05413850",
                   "target_id":"NCT05413850"
                },
                {
                   "span":[266, 267],
                   "type":"citation",
                   "label":"7",
                   "target_id":"c7"
                },
                {
                   "span":[303, 310],
                   "type":"table-ref",
                   "label":"Table 1",
                   "target_id":"tbl1"
                }
             ],
             "raw_xml":"<p hwp:id=\"p-25\">Using dosimetry data from a Phase 1 trial of novel RLT,<sup>177</sup>Lu-rhPSMA-10.1, in 13 patients with metastatic castration-resistant prostate cancer [<ext-link l:rel=\"related\" l:ref-type=\"CLINTRIALGOV\" l:ref=\"NCT05413850\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05413850\" hwp:id=\"ext-link-3\">NCT05413850</ext-link>], time–activity curves were generated for the first treatment cycle (Cycle 1) for each of the 13 participants (<italic toggle=\"yes\"><xref ref-type=\"bibr\" rid=\"c7\" hwp:id=\"xref-ref-7-1\" hwp:rel-id=\"ref-7\">7</xref></italic>). Patient details are described in<xref rid=\"tbl1\" ref-type=\"table\" hwp:id=\"xref-table-wrap-1-1\" hwp:rel-id=\"T1\">Table 1</xref>.</p>",
             "plain_text":"Using dosimetry data from a Phase 1 trial of novel RLT,177Lu-rhPSMA-10.1, in 13 patients with metastatic castration-resistant prostate cancer [NCT05413850], time–activity curves were generated for the first treatment cycle (Cycle 1) for each of the 13 participants (7). Patient details are described in Table",
             "minimal_xml":"<p hwp:id=\"p-25\">Using dosimetry data from a Phase 1 trial of novel RLT,<sup>177</sup>Lu-rhPSMA-10.1, in 13 patients with metastatic castration-resistant prostate cancer [<extlink href=\"NCT05413850\">NCT05413850</extlink>], time–activity curves were generated for the first treatment cycle (Cycle 1) for each of the 13 participants (<bibliography target=\"c7\">7</bibliography>). Patient details are described in <table target=\"tbl1\">Table 1</table>.</p>",
          }
       ]
    }
 }

Citations

Citation fields

  • id: Unique citation identifier (e.g., "c1", "c2")

  • raw: Original citation text

  • xml: Structured XML with metadata

  • text: Normalized citation text

  • label: Citation label/number

  • xml_minimal: Simplified XML (optional)

ASSETS OBJECT
{
   "public_id":"1642632597.v1",
   "open_access":true,
   "normalized":true,
   "updated_at":"2025-10-12T20:44:54.501Z",
   "data":{
      "citations":[
         {
            "id":"c1",
            "label":"1",
            "raw":"Kratochwil C. , Bruchertseifer F. , Giesel FL. 225Ac–PSMA–617 for PSMA–targeted α–radiation therapy of metastatic castration–resistant prostate cancer. J Nucl Med. 57 (12) 1941–1944 (2016).",
            "xml":"<citation publication-type=\"journal\" citation-type=\"journal\" ref:id=\"2025.08.08.25333110v1.1\" ref:linkable=\"yes\" ref:use-reference-as-is=\"yes\" hwp:id=\"citation-1\"><string-name name-style=\"western\" hwp:sortable=\"Kratochwil C\"><surname>Kratochwil</surname><given-names>C</given-names></string-name>,<string-name name-style=\"western\" hwp:sortable=\"Bruchertseifer F\"><surname>Bruchertseifer</surname><given-names>F</given-names></string-name>,<string-name name-style=\"western\" hwp:sortable=\"Giesel FL\"><surname>Giesel</surname><given-names>FL</given-names></string-name>,<etal>et al.</etal><article-title hwp:id=\"article-title-2\">225Ac-PSMA-617 for PSMA-targeted α-radiation therapy of metastatic castration-resistant prostate cancer</article-title>.<source hwp:id=\"source-1\">J Nucl Med</source>.<year>2016</year>;<volume>57</volume>(<issue>12</issue>):<fpage>1941</fpage>–<lpage>1944</lpage>.</citation>",
            "xml_minimal":"<citation><string-name><surname>Kratochwil</surname><given-names>C</given-names></string-name>,<string-name><surname>Bruchertseifer</surname><given-names>F</given-names></string-name>,<string-name><surname>Giesel</surname><given-names>FL</given-names></string-name>,<etal>et al.</etal><article-title>225Ac-PSMA-617 for PSMA-targeted α-radiation therapy of metastatic castration-resistant prostate cancer</article-title>.<source>J Nucl Med</source>.<year>2016</year>;<volume>57</volume>(<issue>12</issue>):<fpage>1941</fpage>–<lpage>1944</lpage>.</citation>"
            "text":"Kratochwil C , Bruchertseifer F , Giesel FL , et al. 225Ac-PSMA-617 for PSMA-targeted α-radiation therapy of metastatic castration-resistant prostate cancer . J Nucl Med . 2016 ; 57 ( 12 ): 1941 – 1944 .",
         }
      ]
   }
}

Last updated